Know More About Cancer Immunotherapy vs Chemotherapy
Immunotherapy tends to give an all-new beginning to the patient and stands head-to-head when compared with standard chemotherapy and the immunotherapy drug nivolumab, Clinical trial research has found that people with squamous non-small cell lung cancer who were treated with nivolumab have lived 3.2 months on an average more than those who were treated with chemotherapy.
Read More